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In patients with aneurysmal subarachnoid haemorrhage (SAH), abnormalities on ECG predict poor outcome, to some extent independently. This applies particularly to signs of cardiac ischaemia. These changes on ECG do not herald impending heart disease but reflect adverse intracranial factors.' The changes indicate myocardial damage, which in turn would result from high plasma noradrenaline concentrations, mediated by either systemic hypertensive effects leading to left ventricular strain, or by direct toxicity. 2 Hypothalamic damage has been implicated as the cause of raised concentrations of plasma noradrenaline,34 either indirectly, through the adrenal glands, or directly, via release of noradrenaline by sympathetic nerve terminals in the myocardium.
In this study we set out to investigate the association between noradrenaline, ECG changes (particularly cardiac ischaemia), and outcome characteristics. To distinguish between non-specific stress of disease (also present in SAH) and noradrenaline released as a result of hypothalamic damage in SAH, we introduced a control group of patients who had undergone elective surgery of the mandible (pain) and who had to remain on an intensive care unit (stress) for at least one day.
Patients and methods
We prospectively studied a series of 37 consecutive patients with clinical and radiological evidence of aneurysmal SAH.56 All patients were admitted within 72 hours of the presenting haemorrhage. Twenty five patients underwent aneurysm surgery at about day 12 after the presenting SAH.
The level of consciousness on admission was assessed with the 14 point Glasgow coma scale score.7 The amount of intraventricular blood on the admission CT was graded separately for each of the four ventricles on a semiquantitative scale of 0 (no blood) to 3 (completely filled with blood). Day after inclusion Day after inclusion 135 CT scans. A combination of rebleeding and infarction occurred in five patients. The occurrence of infarction or rebleeding was not related to the concentrations of noradrenaline.
Discussion
Most patients with SAH as well as controls had increased noradrenaline concentrations on most days, although the variance of these values was large. Patients and controls were both exposed to pain and to the stress of an intensive care unit, which allowed us to distinguish changes in noradrenaline concentrations from hypothalamic damage, expected only in patients with SAH. There were no obvious differences between patients and controls with regard to severity of pain or to prescribed medication. Controls had the highest values of plasma noradrenaline, probably explained by strong physical stress resulting from operation. Individual ECG abnormalities were not obviously related to clinical and radiological characteristics at baseline, as described before.' Therefore we used a combination of ECG abnormalities as possible indices of cardiac ischaemia, the broader category of which is known to be related to outcome.' 17 As patients and controls were comparable with regard to age, cardiovascular history, and blood pressure, we assumed that the proportion of pre-existent ECG abnormalities in both groups was also similar. Nevertheless, we found twice as many abnormal ECGs in patients as in controls.
Despite the high plasma noradrenaline in controls, cardiac ischaemia was much rarer than in patients with SAH. This difference in occurrence of cardiac ischaemia and plasma noradrenaline concentrations between the groups was large and significant. Therefore we think that, although plasma noradrenaline concentrations reflect myocardial noradrenaline concentrations only indirectly and probably incompletely, high plasma noradrenaline concentrations in patients with SAH are not a sufficient explanation for the development of cardiac ischaemia, by contrast with generally held beliefs.2 Grad et al'8 also concluded that ECG changes did not depend on raised plasma noradrenaline concentrations, but they did not adjust for clinical and radiological factors, or study a control group. Theoretically, we may have missed a very early rise in noradrenaline as a result of the primary impact of the haemorrhage on the hypothalamus, but as 65% of the patients were entered in the study within 24 hours of the haemorrhage this is unlikely.
The association between increased cardiac enzymes and cortisol on the one hand and cardiac ischaemia on the other was marginal; apparently structural damage of the myocardium can often be mild (normal enzymes), and still cause signs of cardiac ischaemia on the ECG.
Cardiac ischaemia is associated with poor outcome, but in a previous study we showed that this association is indirect, in that ECG changes reflect the impact of the primary bleeding, perhaps via hypothalamic damage, that results in increased secretion of noradrenaline.' In the first three days of our study period there were no significant differences in noradrenaline concentrations between patients with good and poor outcome; from day 6 onwards the differences in noradrenaline concentrations between patients with good and poor outcome became more clear. Stratification for known predictors of poor outcome (Glasgow coma scale score <14, amount of subarachnoid blood >20, amount of intraventricular blood >2, presence of an intracerebral haematoma, or age >53 years), however, showed that noradrenaline concentrations are not independently related to outcome. In addition the clinical and radiological factors have more practical value as predictors of poor outcome than increased noradrenaline concentrations, as they can be obtained on the day of admission.
The cause of delayed cerebral ischaemia after SAH is largely unknown. Although noradrenaline has often been implicated as the causative factor,'9 we were not able to find an association between raised plasma noradrenaline and infarction in our patient group, which is in agreement with another recent study.20 The occurrence of rebleeding was not associated with raised noradrenaline either.
In conclusion, raised plasma noradrenaline concentrations after SAH do not explain cardiac ischaemia. Both factors should be considered indirect measures of cerebral damage (probably via hypothalamic damage). Therefore, the prediction of complications and poor outcome from the Glasgow coma scale score and the CT findings on admission is more relevant, more accurate, and more practical than assessment of noradrenaline or identification of ECG abnormalities.
